Abbott jumps as jury says company, Reckitt not liable in infant formula case
Abbott Labs (ABT) and competitor Reckitt Benckiser's (OTCPK:RBGPF) Mead Johnson business are facing more than 1,000 lawsuits that allege that the companies failed to warn parents about the NEC risks with cow’s-milk-based products. "We are pleased with ...
CNBC’s Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that’s been weighed down by ...
Marie Thibault, an analyst from BTIG, reiterated the Buy rating on Abbott Laboratories (ABT – Research Report). The associated price ...
Abbott Laboratories on Wednesday reported better-than-expected third-quarter earnings and sales, boosted by strength in the ...
Tribune News Service on MSN11h
Hundreds of lawsuits allege Abbott Laboratories’ formula for premature infants made babies sick. But is the formula to blame?To Dioselina Salto, the first two weeks of motherhood were amazing, even though she spent much of it in the hospital after ...
Shares of Abbott Laboratories are rising and those of Reckitt Benckiser are gaining in London trading Friday, a day after a ...
Abbott Laboratories, a healthcare giant with diverse divisions, is normalizing post-pandemic as its medical devices drive ...
In closing arguments on Wednesday, plaintiff's lawyer Timothy Cronin asked jurors for $6 billion in punitive damages.
3don MSN
Mad Money' host Jim Cramer takes a closer look at the litigation facing Abbott Labs.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback